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Abstract
Background: Infection with the HIV and AIDS are leading causes of morbidity and mortality among women and
children worldwide. Prevention of mother-to-child transmission of HIV (PMTCT) programs were developed to
protect women and their babies from having HIV infection. However, knowledge on how male participation has
been applied to these programs is limited. We present a research protocol for a review which seeks to determine
the effects of male participation on female uptake of PMTCT programs, and assess how this male participation has
been investigated and documented worldwide.
Methods: This is a systematic review of published literature. We will attempt to identify all studies relevant to the
subject written in the English language from January 1998 to June 2011. Electronic searches of the PubMED, EMBASE,
CINAHL, and LILACS databases will be conducted using the relevant medical subject headings. Reference lists of
identified studies and previous reviews will be manually checked for articles of interest. We shall also contact authors on
the field for any relevant material. Two authors (FM and LM) will independently screen potential articles for eligibility
using well-defined inclusion and exclusion criteria. They will independently assess the methodological quality of each
included paper using the Jadad scale for randomized controlled trials, and the Newcastle-Ottawa scale for observational
studies. Then they will independently extract data from the studies using a pre-established data extraction form. The
primary outcome data will be female uptake of PMTCT services following a male/couple intervention, while secondary
outcome measures will include indicators and barriers of male participation in PMTCT activities among others. During the
data extraction process, discrepancies between the two authors will be sorted out by discussion or consultation with a
third party (LT). The analysis and reporting of the review will be according to the PRISMA and MOOSE guidelines. Any
identified clinical or statistical heterogeneity will be explored. Where possible, a random-effects meta-analysis will be
performed to obtain aggregate estimates. We will also assess publication bias using funnel plots. Analysis of other
outcomes will be descriptive.
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Background
Infection with the HIV and AIDS continue to be leading
causes of morbidity and mortality among women and
children worldwide [1]. According to 2008 estimates,
over 430,000 children were newly infected with HIV,
and over 90% of these were through mother-to-child
transmission (MTCT) of HIV [2]. MTCT of HIV can
occur during pregnancy, labour, delivery, and during
breastfeeding. In the absence of any intervention there
is a 20% to 45% transmission rate from mother to child,
but this risk can drop to 2% in non-breastfeeding popu-
lations, and 5% in breastfeeding populations in which
specific interventions are carried out [2]. These inter-
ventions include: providing lifelong antiretroviral treat-
ment (ART) for all pregnant women with CD4 ≤350
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3 or advanced clinical disease; providing combi-
nation antiretroviral (ARV) prophylaxis with either
Zidovudine (AZT) or triple ARV prophylaxis beginning
i nt h es e c o n dt r i m e s t e ra n dl i n k e dt op o s t p a r t u mp r o -
phylaxis; providing prophylaxis to either the mother or
the infant during breastfeeding in settings where breast-
feeding is the preferred feeding option [2].
The Global Fund Board recognizes prevention of HIV
infection among women, prevention of death among
HIV positive women, and preventing babies from being
infected with HIV, as crucial priorities [1]. Prevention of
mother-to-child transmission (PMTCT) of HIV pro-
grams were developed since 1998 to protect women and
their babies from infection. At present the World Health
Organization (WHO) promotes a comprehensive four-
pronged approach for PMTCT. This includes: prevent-
ing HIV infection among women of childbearing age;
preventing unintended pregnancies among women living
with HIV; preventing HIV transmission from a woman
living with HIV to her infant; and providing appropriate
treatment, care, and support to mothers living with
HIV, their children, and their families [2]. These pro-
grams are more focused on women and generally omit
men. The following pertinent questions therefore stand
out: What is the effect of male participation in prevent-
ing MTCT of HIV among pregnant women, and how
has this participation been documented worldwide?
Knowledge on how male participation has been
applied to national PMTCT programs worldwide is lim-
ited. The male partner plays an important role in
women’s reproductive health and improvement of
PMTCT outcomes. This role of the male partner in
women’s risk of acquiring HIV, in the uptake of volun-
tary counseling and testing (VCT) of HIV and PMTCT
programs has been described in many studies [3-6].
Other observational studies indicate that educating men
about the importance of family healthcare improves
health-seeking behavior for antenatal care and child
immunization [7,8] and also enhances communication
and support of the female partner [9,10]. This evidence
suggests that male partner involvement is crucial. The
importance of male partner participation is also recog-
nized by the WHO in their 2010 PMTCT Strategic
Vision document where it is stated that “male partners
play an equally important role in the scale-up of
PMTCT services” [2].
In this era of the HIV/AIDS epidemic, more attention
is directed towards incorporating men into reproductive
health education interventions [11]. Involving men in
PMTCT services could increase the uptake of couple
counseling and disclosure of HIV status. This would
open doors for the provision of services to HIV-negative
couples and discordant couples, as well as preventive
care and treatment for HIV-positive couples and their
families [12]. Male involvement could enhance partner
support for follow-up care for HIV-positive pregnant
women and HIV-exposed infants, including ARV adher-
ence, improved adherence to infant feeding methods,
and early management of HIV-exposed infants [12]. It
could also eliminate harmful consequences faced by
women who seek PMTCT services such as stigmatiza-
tion and gender-based violence. Moreover, male involve-
ment in PMTCT services could address the healthcare
needs and responsibilities of men, providing them with
positive male norms, and linking them to other health-
care services [12].
This review seeks to determine the effect of male par-
ticipation on female uptake of PMTCT services, and
assess how male participation in PMTCT has been
investigated, described, promoted, and documented
worldwide. It will summarize the evidence for and
against male participation in PMTCT programs and
review the interventions which have been investigated in
enhancing male participation in PMTCT activities. It
would provide a solid evidence base for advocating
increased male participation in PMTCT activities. It
would also help formulate recommendations on how to
increase male participation in PMTCT activities. From
the evidence in the review, we plan to formulate a stan-
dardized Scale for the Assessment of Male Participation
in PMTCT programs (SAMP-PMTCT). If validated, this
scale would serve as a useful tool in assessing the level
of male participation in PMTCT activities.
Objectives
The primary objective of this systematic review is to
determine the effect of male participation on female
uptake of PMTCT services.
The secondary objectives are: to determine the per-
centage of men who accept voluntary counseling and
testing for HIV, provide moral and financial support to
their spouses to adhere to antenatal care (ANC) and
PMTCT guidelines; to identify indicators of male parti-
cipation in PMTCT activities (supportive and non-sup-
portive); to evaluate men’s knowledge and approval of
PMTCT interventions; to evaluate determinants of male
involvement in PMTCT and antenatal care; to evaluate
interventions used to enhance male participation in
PMTCT; to identify barriers to male participation in
PMTCT programs; and to determine potential interven-
tions for improving male involvement in ANC and
PMTCT activities.
Methods
Criteria for considering studies for this review
Types of studies
Randomized controlled trials and observational studies
will be selected for the review.
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Included studies must have been conducted in a context
o fA N Ca n d / o rP M T C To fH I V .W ew i l lu s el i t e r a t u r e
from any geographic or socioeconomic setting.
Types of participants
Participants shall include men, women, or focused
groups of the community. Irrespective of the type of
participants, we shall include studies that report out-
comes that could possibly (theoretically) affect female
uptake of PMTCT services, regardless of whether uptake
data are reported.
Outcome measures
T h ep r i m a r yo u t c o m eo ft h i sr e v i e ww i l lb ef e m a l e
uptake of PMTCT services following a male/couple
intervention.
Secondary outcomes would include: the proportion of
men who accept voluntary counseling and testing for
HIV, provide moral and financial support to their
spouses to adhere to antenatal care and PMTCT guide-
lines; indicators of male participation in PMTCT activ-
ities; men’s knowledge of PMTCT; men’sk n o w l e d g eo f
MTCT of HIV; proportion of men who approve
PMTCT; determinants of male involvement in PMTCT
programs and ANC; percentage of women receiving
VCT for HIV and obtaining their results; percentage of
HIV-positive pregnant women accepting ARVs; couple
uptake of VCT; number of men coming for services as a
result of provider invitation; barriers to male partner
participation in ANC and PMTCT activities: we will col-
late all the barriers to male partner participation as
reported by the authors; suggestions for improving male
involvement in ANC and PMTCT activities.
Search strategy for identification of studies
We shall attempt to identify all studies relevant to the
review, written in English from the beginning of the
year 1998 (year of introduction of PMTCT programs) to
June 2011.
Electronic searches
We will search the PubMED, EMBASE, CINAHL, and
LILACS databases for relevant articles written in English
from January 1998 to June 2011. We will use the subject
term services of the different databases. The following
search terms and their MeSH (medical subject heading)
equivalents will be used: HIV, male, spouse, partner,
men, couple, pregnancy, gestation, participation, involve-
ment, engagement, antenatal, barriers, facilitators, dis-
close, declare, testing, PMTCT, voluntary counseling
and testing (VCT), vertical transmission, domestic vio-
lence. These terms will be used in varying combinations.
The term HIV will be present in every search.
Reference lists
We will manually check the reference list of all the stu-
dies identified by the above search strategy. Relevant
studies shall be observed, and where appropriate,
included in the review.
We shall also check the reference list of any previous
reviews on male participation and PMTCT for any rele-
vant articles which could be included in the review.
Grey literature
We will attempt to contact authors, experts in the field,
and research organizations for any relevant material.
Data collection and analysis
Screening
Two authors (FM and LM), working independently, will
screen all citations and abstracts identified by the search
strategy to identify eligible papers. The full text of eligi-
ble articles will be obtained. These will be assessed
using a pre-designed eligibility form based on the inclu-
sion criteria. Eligible studies will be included in the
review. Disagreements will be resolved by discussion or
by seeking the opinion of a third party (LT).
Authors will be contacted in order to clarify missing
aspects or unclear information.
Ineligible studies will be excluded from the review and
the reason for exclusion stated in a table.
Data extraction
The two authors (FM and LM) will independently extract
data from the studies using a pre-established data extrac-
tion form (see sample example in Additional file 1). Infor-
mation obtained will include the site of the study, the
purpose of the study, the study design, the study settings,
participant characteristics, interventions if any, outcomes,
forms of male participation, and so on. Discrepancies in
the extracted data will be discussed by the two authors for
consensus; if not, this will be reviewed by a third party
(LT). In case of unclear or incomplete data, we will con-
tact the authors for further details.
Assessment of methodological quality
Two authors (FM and LM) will independently assess the
methodological quality of included studies using the
Jadad scale [13] for randomized controlled trials, and
the Newcastle-Ottawa scale [14] for observational stu-
dies. In case of doubt or missing details, authors will be
contacted for clarification. Discrepancies will be dis-
cussed by the two authors for a consensus. If an agree-
ment is not reached a third party (LT) will be consulted.
Measures of intervention effect
We shall use the Review Manager Version 5.1 software
for analysis, and results will be presented using 95%
confidence intervals. The odds ratio and the relative risk
will be used to measure intervention effects for dichoto-
nomous data. In case of continuous outcomes, the mean
difference will be calculated when outcome measures in
all studies are made on the same scale. However, if out-
comes are measured in different scales, the standardized
mean difference will be assessed.
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We will assess the participants, methods, and interven-
tion effects of included studies for heterogeneity. This
will enable us determine whether results can be pulled
across studies. Any identified clinical or statistical het-
erogeneity will be explored visually or using the chi
square test. Possible sources of heterogeneity include
geographical location (developed versus developing
country), age groups, marital status, study design. In
case of heterogeneity, subgroup analyses according to
these different categories will be conducted. If included
studies are similar enough to combine, a fixed-effect
meta-analysis will be conducted. Otherwise, a random-
effects meta-analysis will be performed to incorporate
heterogeneity among studies and obtain aggregate
estimates.
Sensitivity analyses
A sensitivity analysis will be performed to determine any
bias introduced by the eligibility criteria, the data ana-
lyzed, the analysis method, and other relevant issues
identified during the review process.
Presenting and reporting of results
The analysis and reporting of the review will be done
according to the PRISMA [15] and MOOSE [16] guide-
lines. We will use a flow diagram to summarize the
selection process of the studies. Agreement between
data abstractors will be assessed using the kappa statistic
[17].
We will also assess publication bias using funnel plots.
A “summary of findings” table will be used to present
the most important outcomes. Reporting of other out-
comes will be descriptive.
Discussion
Expected significance of the study
From the evidence in the review, we hope to formulate
in a subsequent project, a standardized Scale for the
Assessment of Male Participation in PMTCT programs
(SAMP-PMTCT). This scale would be objective and
generalizable in a wide range of settings. During this
subsequent project the validity and reliability of this
scale will be tested and at the same time, it will be used
to evaluate the level of male participation in PMTCT
programs in our setting.
Moreover, the data derived from the review could
inform the design of a randomized clinical trial on inter-
ventions aimed at improving partner attendance in
PMTCT activities. We foresee an intervention arm
which may include invitations to participate, financial
incentives, home visits, and other motivational factors
identified from the review. The control arm will consist
of women who take part in PMTCT activities alone.
Our outcomes would include acceptance of HIV screen-
ing, transmission rates to children, obstetric outcomes,
and patient satisfaction. This would provide a solid evi-
dence base for policy formulation on the integration of
men in PMTCT activities. Once these policies are
implemented, they could further help in preventing
MTCT of HIV worldwide, and would be a major contri-
buting step in the fight against HIV.
Additional material
Additional file 1: General description of what to include in the data
extraction form. This form broadly describes the information which we
hope to extract using the data extraction. It includes general information
about the included studies, an assessment of the inclusion criteria, and
brings out the interventions (if any) used in the studies. This form also
has a section showing what was measured at the end of each study, the
summary statistics that were used, and the result summaries in each
case.
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